Protneteomix specializes in biomedical
postgenomics and proteomics and offers high-throughput protein
interactions
services for basic and applied research as well as fabricates antibody
arrays
to elucidate protein behaviour in diseases cells and biological fluids.
The
feasibility of the technology several has been proven with breast
cancer cell
lines.
The developed technology
permits
multiplexed screening of various target biomolecules (proteins,
peptides,
antigens, nucleic acids, lipids, carbohydrates and small ligands).
